We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

115 hedge funds and large institutions have $377M invested in Spectrum Pharmaceuticals Inc in 2013 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

5% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 41

1% more capital invested

Capital invested by funds: $374M → $377M (+$3.07M)

3% less funds holding

Funds holding: 118115 (-3)

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

48% less call options, than puts

Call options by funds: $1.88M | Put options by funds: $3.62M

Holders
115
Holders Change
-3
Holders Change %
-2.54%
% of All Funds
3.34%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
12
Increased
43
Reduced
41
Closed
15
Calls
$1.88M
Puts
$3.62M
Net Calls
-$1.74M
Net Calls Change
-$312K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
26
Deutsche Bank
Germany
$2.17M +$968K +108,411 +79%
BIM
27
BlackRock Investment Management
Delaware
$2.15M -$34.6K -3,878 -2%
CEI
28
Clark Estates Inc
New York
$2.04M
Bank of Montreal
29
Bank of Montreal
Ontario, Canada
$1.99M +$1.94M +217,728 +3,195%
Ameriprise
30
Ameriprise
Minnesota
$1.89M +$71.7K +8,023 +4%
Macquarie Group
31
Macquarie Group
Australia
$1.83M +$173K +19,400 +10%
California Public Employees Retirement System
32
California Public Employees Retirement System
California
$1.63M -$22.3K -2,500 -1%
PP
33
PDT Partners
New York
$1.56M -$703K -78,700 -31%
U
34
UBS
Switzerland
$1.47M +$1.33M +149,180 +906%
Charles Schwab
35
Charles Schwab
California
$1.35M +$34.7K +3,888 +3%
CS
36
Credit Suisse
Switzerland
$1.29M +$308K +34,527 +31%
Invesco
37
Invesco
Georgia
$1.27M +$91.4K +10,231 +8%
Public Sector Pension Investment Board (PSP Investments)
38
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.16M +$25K +2,800 +2%
PAM
39
Panagora Asset Management
Massachusetts
$1.08M +$416K +46,561 +62%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$1.06M
Prudential Financial
41
Prudential Financial
New Jersey
$1.05M +$6.25K +700 +0.6%
SC
42
Sculptor Capital
New York
$1.02M
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$1.01M +$5.36K +600 +0.5%
BG
44
BlackRock Group
United Kingdom
$989K +$73.2K +8,192 +8%
ARTA
45
A.R.T. Advisors
New York
$980K +$507K +56,744 +105%
AllianceBernstein
46
AllianceBernstein
Tennessee
$948K -$107 -12 -0%
State of Tennessee, Department of Treasury
47
State of Tennessee, Department of Treasury
Tennessee
$853K -$24.1K -2,700 -3%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$828K -$58.5K -6,550 -7%
TA
49
Teachers Advisors
New York
$773K +$44.1K +4,940 +6%
Wells Fargo
50
Wells Fargo
California
$767K -$198K -22,153 -20%

SPPI Hedge Fund Activity: Q4 2013 in Review

115 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q4 2013, worth a combined $377M — up 0.82% from $374M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SPPI and 12 opened new positions — a net loss of 3 holders — while 41 trimmed existing stakes and 43 added.

The largest buyer was Royal Bank of Canada, adding an estimated $10.4M. The largest seller was D.E. Shaw & Co, cutting an estimated $9.31M.

  • 115 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q4 2013, down from 118 in Q3 2013.
  • Funds reported $377M of Spectrum Pharmaceuticals Inc stock for Q4 2013, up 0.82% quarter-over-quarter.
  • 12 funds opened new Spectrum Pharmaceuticals Inc positions in Q4 2013 and 15 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q4 2013 was Royal Bank of Canada, an estimated $10.4M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q4 2013 was D.E. Shaw & Co, an estimated $9.31M sold.

Based on aggregated 13F filings for Q4 2013.